HIV infection among voluntary blood donors in Shijiazhuang, 2011-2021
10.13303/j.cjbt.issn.1004-549x.2023.02.021
- VernacularTitle:2011～2021年石家庄地区无偿献血者HIV感染情况分析
- Author:
Yazi ZHAO
1
;
Xianyuan WANG
1
;
Yanbin WANG
1
;
Huixian ZHANG
1
;
Wei HAN
1
Author Information
1. Hebei Blood Center, Shijiazhuang 050071, China
- Publication Type:Journal Article
- Keywords:
HIV;
voluntary blood donors;
confirmed positive
- From:
Chinese Journal of Blood Transfusion
2023;36(2):180-182
- CountryChina
- Language:Chinese
-
Abstract:
【Objective】 To study the characteristics of HIV infection among voluntary blood donors in Shijiazhuang from 2011 to 2021, so as to provide reference for decision making in the control of HIV for blood centers. 【Methods】 The confirmatory results of HIV reactive samples in initial screening among voluntary blood donors from 2011 to 2021 in our center were statistical analyzed. 【Results】 A total of 2 008 299 samples from 1 667 315 blood donors were detected, among which 3 217 samples were HIV reactive and 234 were confirmed positive, with the positive rate at 11.65/100 000 and the prevalence of 14.03/100 000. The prevalence in men was higher than that in women (16.52/100 000 vs 1.39/100 000), in first-time blood donors higher than that in repeated donors (17.27/100 000 vs 8.12/100 000), in whole blood donors higher than that in plateletpheresis donors (12.01/100 000 vs 8.41/100 000), and the differences were statistically significant (P<0.05). The male homosexual transmission was the main routes of transmission, accounting for 62.39% (146/234). And 72% of double-reagent reactive samples were confirmed positive. Four samples were screened in the serological window period and 6 samples were from HIV positive confirmed donors. 【Conclusion】 The HIV prevalence among voluntary blood donors in Shijiazhuang was low. A certain percentage of repeated blood donors got newly infected. NAT could shorten the detection window period of HIV. Since some confirmed positive samples had not been detected out by NAT, publicity and education should be strengthened to reduce the probability of infected or high-risk groups to participate in blood donation.
